Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo clinic experience

Mayo Clinic Proceedings

Volumn 78, Issue 6, 2003, Pages 708-715

  Wahner Roedler, Dietlind L ^a   Nelson, Diana F ^a   Croghan, Ivana T ^a   Achenbach, Sara J ^a   Crowson, Cynthia S ^a   Hartmann, Lynn C ^a   O'Fallon, W Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MORBIDITY; RADIATION DOSE; RADIATION INJURY; RISK FACTOR; SELF EXAMINATION; SPLENECTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0038388757     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.6.708     Document Type: Article

References (38)

1. Goss PE, Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol. 1998;16:338-347.
2. Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. Management of breast cancer after Hodgkin's disease. J Clin Oncol. 2000;18:765-772.
3. Gervais-Fagnou DD, Girouard C, Laperriere N, Pintillie M, Goss PE. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology. 1999;57:224-231.
4. Clemons M, Loijens L, Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev. 2000;26:291-302.
5. Cutuli B, Borel C, Dhermain F, et al. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiother Oncol. 2001;59:247-255.
6. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988;318:76-81.
7. Kaldor JM, Day NE, Band P, et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer. 1987;39:571-585.
8. Curtis RE, Boice JD Jr. Second cancers after radiotherapy for Hodgkin's disease [letter]. N Engl J Med. 1988;319:244-245.
9. McCullagh P, Nelder JA. Generalized Linear Models. New York, NY: Chapman and Hall; 1983.
10. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
11. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 1993;85:25-31.
12. Mauch PM, Kalish LA, Marcus KC, et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996;87:3625-3632.
13. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-751.
14. Travis LB, Curtis RE, Boice JD Jr. Late effects of treatment for childhood Hodgkin's disease [letter]. N Engl J Med. 1996;335:352-353.
15. Metayer C, Lynch CF, Clarke EA, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18:2435-2443.
16. O'Brien PC, Barton MB, Fisher R, Australasian Radiation Oncology Lymphoma Group (AROLG). Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australas Radiol. 1995;39:271-276.
17. Cellai E, Magrini SM, Masala G, et al. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1,524 cases consecutively treated at the Florence University Hospital. Int J Radiat Oncol Biol Phys. 2001;49:1327-1337.
18. Tokunaga M, Land CE, Tokuoka S, Nishimori I, Soda M, Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res. 1994;138:209-223.
19. Salloum E, Doria R, Schubert W, et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol. 1996;14:2435-2443.
20. Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willet CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997;79:1203-1210.
21. Chung CT, Bogart JA, Adams JF, et al. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1997;37:405-409.
22. Beaty O III, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol. 1995;13:603-609.
23. Dietrich PY, Henry-Amar M, Cosset JM, Bodis S, Bosq J, Hayat M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood. 1994;84:1209-1215.
24. Wolden SL, Lamborn KR, Cleary SF, Tate DJ, Donaldson SS. Second cancers following pediatric Hodgkin's disease. J Clin Oncol. 1998;16:536-544.
25. Howe HL, Wingo PA, Thun MJ, et al. The Annual Report to the Nation of the Status of Cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842.
26. Linet MS, Nyren O, Gridley G, et al. Risk of cancer following splenectomy. Int J Cancer. 1996;66:611-616.
27. Lippman ME. Epidemiology of breast cancer. In: Lippman ME, Lichter AS, Danforth DN Jr, eds. Diagnosis and Management of Breast Cancer. Philadelphia, Pa: WB Saunders Co; 1988:1-9.
28. SEER Cancer Statistics Review, 1973-1998. Available at: http://seer cancer.gov/Publications/CSR1973_1998. Accessibility verified February 19, 2002.
29. Yahalom J, Petrek JA, Biddinger PW, et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol. 1992;10:1674-1681.
30. de la Rochefordiere A, Asselain B, Scholl S, et al. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys. 1994;30:35-41.
31. Roubidoux MA, Helvie MA, Lai NE, Paramagul C. Bilateral breast cancer: early detection with mammography. Radiology. 1995;196:427-431.
32. Janov AJ, Tulecke M, O'Neill A, et al. Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study. Breast J. 2001;7:46-52.
33. Karasek K, Deutsch M. Lumpectomy and breast irradiation for breast cancer after radiotherapy for lymphoma. Am J Clin Oncol. 1996;19:451-454.
34. Deutsch M, Gerszten K, Bloomer WD, Advisar E. Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma. Am J Clin Oncol. 2001;24:33-34.
35. Aref I, Cross P. Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease. Br J Radiol. 2000;73:905-906.
36. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
37. Tinger A, Wasserman TH, Klein EE, et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys. 1997;37:865-870.
38. Zellmer DL, Wilson JF, Janjan NA. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation. Int J Radiat Oncol Biol Phys. 1991;21:1343-1351.